FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways. - Dixit G; Gonzalez-Bosquet J; Skurski J; Devor EJ; Dickerson EB; Nothnick WB; Issuree PD; Leslie KK; Maretzky T (Clinical and translational medicine, 2023)